Mingyue Optical Lens Co.,Ltd. (SHE:301101)

China · Delayed Price · Currency is CNY

29.90

-0.33 (-1.09%)

At close: Sep 30, 2026

Market Cap	6.00B -31.1%
Revenue (ttm)	884.86M +12.8%
Net Income	208.49M +13.7%
EPS	1.04 +13.5%
Shares Out	200.73M
PE Ratio	28.79
Forward PE	24.81
Dividend	0.50 (1.67%)
Ex-Dividend Date	May 27, 2026

Volume	1,202,305
Open	30.25
Previous Close	30.23
Day's Range	29.85 - 30.46
52-Week Range	26.05 - 49.90
Beta	0.33
Analysts	Strong Buy
Price Target	41.00 (+37.12%)
Earnings Date	Oct 23, 2026

About Mingyue Optical Lens

Mingyue Optical Lens Co.,Ltd. engages in the research and development, design, and production of lenses, lens raw materials, finished mirrors, and frames in China and internationally. The company offers myopia management for teenagers, progressive multifocal lenses, photochromic lenses, custom lenses, anti-fatigue lenses, outdoor polarized myopia sunglasses, KR lenses, post-operative protection lenses, and other product series. It also engages in wholesale and retail trade; and technology promotion and application service industry. Mingyue Opti... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2002

Employees 1,066

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301101

Full Company Profile

Financial Performance

In 2025, Mingyue Optical Lens's revenue was 827.50 million, an increase of 7.43% compared to the previous year's 770.30 million. Earnings were 192.92 million, an increase of 9.13%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 301101 stock is "Strong Buy." The 12-month stock price target is ¥41.00, which is an increase of 37.12% from the latest price.

Price Target

¥41.00

(37.12% upside)

Analyst Consensus: Strong Buy

Stock Forecasts